Abbott Laboratories (BCBA:ABT)

Market Cap	286.67T
Revenue (ttm)	45.44T
Net Income (ttm)	14.43T
Shares Out	n/a
EPS (ttm)	8,264.67
PE Ratio	19.86
Forward PE	25.04
Dividend	541.76 (1.32%)
Ex-Dividend Date	May 17, 2025

Volume	86
Average Volume	345
Open	42,800
Previous Close	41,575
Day's Range	40,800 - 43,450
52-Week Range	30,325 - 43,925
Beta	n/a
RSI	54.46
Earnings Date	Jul 17, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD